风湿性关节炎患者持续疼痛的影响,尽管缓解状态:来自KOBIO注册表的数据
Hyoun-Ah Kim1, So Young Park2, Kichul Shin2
1Department of Rheumatology, Ajou University School of Medicine, Suwon, Korea.
Journal of rheumatic diseases
|July 21, 2023
概括
许多类风湿性关节炎患者即使在缓解期也会经历持续的疼痛. 脚部侵蚀,神经疾病和皮质类固醇使用与这种中度至重度的疼痛有关.
科学领域:
- 类风湿病学 类风湿病学
- 临床医学 临床医学
- 疼痛管理 疼痛管理
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,其特征是关节炎症.
- 在RA的临床缓解是由低的疾病活动来定义的,但持续的疼痛仍然是许多患者的一个重要问题.
- 了解导致RA缓解疼痛的因素对于改善患者生活质量至关重要.
研究的目的:
- 为了确定在RA患者中疼痛的流行率,这些患者已经实现了临床缓解.
- 确定与缓解期的RA患者持续疼痛相关的人口和临床特征.
- 分析影响中度至重度疼痛的因素,尽管达到缓解.
主要方法:
- 分析了韩国风湿病学学院生物药物和向治疗注册表中的1891名患者的数据.
- 缓解的定义是使用28个关节的疾病活动评分 - 红细胞沉率 (ESR) <2.6.6.
- 使用视觉模拟尺度 (VAS),疼痛强度被分类为严重 (≥7),中度 (4-6.9) 或轻度 (<4).
主要成果:
- 超过一半 (52.6%) 的患者在生物或向合成DMARD治疗期间或开始时报告严重疼痛.
- 尽管随访1年后的缓解率为36.0%,但这些患者中有21.5%的患者经历了中度至严重的疼痛.
- 脚部侵蚀,神经疾病和皮质类固醇使用独立地与RA缓解中中度至重度疼痛相关;ESR和JAK抑制剂使用显示反向关联.
结论:
- 持续性疼痛是临床缓解期的RA患者的常见和重大问题.
- 诸如足部侵蚀,神经相关疾病和皮质类固醇使用等因素有助于持续的疼痛.
- 需要进一步的研究来开发有效的减轻疼痛的策略,并改善缓解的RA患者的生活质量.
相关概念视频
Analgesia and Pain Management
661
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
661
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K


